tiprankstipranks
Beijing Health (Holdings) Limited (HK:2389)
:2389
Hong Kong Market
Want to see HK:2389 full AI Analyst Report?

Beijing Health (Holdings) Limited (2389) AI Stock Analysis

0 Followers

Top Page

HK:2389

Beijing Health (Holdings) Limited

(2389)

Select Model
Select Model
Select Model
Neutral 49 (OpenAI - 5.2)
Rating:49Neutral
Price Target:
HK$0.08
▲(28.33% Upside)
Action:Reiterated
Date:06/17/26
The score is held down primarily by weak financial performance—persistent large losses and mostly negative cash flow—despite low leverage. Technicals offer some near-term support (price above key shorter moving averages with mildly positive momentum), but valuation remains unattractive/unclear due to negative earnings and no indicated dividend yield.
Positive Factors
Low leverage / conservative balance sheet
Very low debt relative to equity and assets gives the company durable financial flexibility. With debt-to-equity near 0.07 and sizable equity versus assets, the firm can fund operations, absorb continued losses, or access credit with lower default risk while restructuring toward profitability.
Negative Factors
Deep, persistent losses and compressed margins
Very large operating and net losses indicate the core business is not yet profitable. Such entrenched negative margins erode reinvestment capacity, limit ability to scale profitably, and require material operational change or cost reduction to achieve sustainable earnings.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage / conservative balance sheet
Very low debt relative to equity and assets gives the company durable financial flexibility. With debt-to-equity near 0.07 and sizable equity versus assets, the firm can fund operations, absorb continued losses, or access credit with lower default risk while restructuring toward profitability.
Read all positive factors

Beijing Health (Holdings) Limited (2389) vs. iShares MSCI Hong Kong ETF (EWH)

Beijing Health (Holdings) Limited Business Overview & Revenue Model

Company Description
Beijing Health (Holdings) Limited, an investment holding company, provides medical, health, and geriatric care related services and products in the People’s Republic of China. It engages in the investment and operation of general health industrial...
How the Company Makes Money
null...

Beijing Health (Holdings) Limited Financial Statement Overview

Summary
Financials are weak overall: profitability remains deeply negative (operating margin ~-63%, net margin ~-64%) despite a modest revenue rebound, and cash flow is a major risk with negative operating cash flow (-5.5M) and negative free cash flow (-18.0M). The main offset is a relatively conservative balance sheet with low leverage (debt-to-equity ~0.07), but ongoing losses continue to erode value (negative ROE).
Income Statement
22
Negative
Balance Sheet
63
Positive
Cash Flow
18
Very Negative
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue157.20M149.94M140.35M166.48M203.78M
Gross Profit42.45M35.68M38.47M46.51M46.99M
EBITDA-77.41M-97.47M-44.19M-75.25M-10.37M
Net Income-100.91M-116.22M-61.88M-97.70M-39.41M
Balance Sheet
Total Assets2.10B1.95B2.18B2.42B2.84B
Cash, Cash Equivalents and Short-Term Investments237.36M211.08M335.96M440.76M496.30M
Total Debt114.16M5.65M4.89M32.75M48.37M
Total Liabilities343.11M209.74M223.82M271.77M341.34M
Stockholders Equity1.66B1.72B1.89B2.04B2.29B
Cash Flow
Free Cash Flow-18.02M-42.20M-45.10M-12.34M406.00K
Operating Cash Flow-5.49M-35.56M-43.72M-11.19M1.99M
Investing Cash Flow154.75M-33.80M74.76M22.77M-227.83M
Financing Cash Flow-88.80M-5.28M-68.40M-17.71M-20.46M

Beijing Health (Holdings) Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.06
Price Trends
50DMA
0.07
Positive
100DMA
0.07
Positive
200DMA
0.07
Positive
Market Momentum
MACD
<0.01
Negative
RSI
71.58
Negative
STOCH
55.71
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2389, the sentiment is Positive. The current price of 0.06 is below the 20-day moving average (MA) of 0.07, below the 50-day MA of 0.07, and below the 200-day MA of 0.07, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 71.58 is Negative, neither overbought nor oversold. The STOCH value of 55.71 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:2389.

Beijing Health (Holdings) Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
67
Neutral
HK$372.44M11.374.28%7.10%-2.78%-24.77%
56
Neutral
HK$471.24M2.9927.04%2.00%
54
Neutral
HK$1.50B105.240.48%0.49%-2.63%
52
Neutral
HK$5.41B109.030.60%-9.81%-72.56%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
49
Neutral
HK$466.53M-4.64-6.02%4.84%13.02%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:2389
Beijing Health (Holdings) Limited
0.08
>-0.01
-8.33%
HK:0286
Aidigong Maternal & Child Health
1.31
0.00
0.00%
HK:3869
Hospital Corporation of China Ltd
3.40
-0.90
-20.93%
HK:3886
Town Health International Medical Group Ltd.
0.22
-0.01
-5.15%
HK:6078
Hygeia Healthcare Holdings Co., Ltd.
8.72
-6.44
-42.48%
HK:0722
UMP Healthcare Holdings Limited
0.47
0.05
10.98%

Beijing Health (Holdings) Limited Corporate Events

Beijing Health Wins Unanimous Shareholder Backing at 2026 AGM
Jun 2, 2026
Beijing Health (Holdings) Limited reported that all resolutions at its 2 June 2026 annual general meeting were approved by shareholders through poll voting, each receiving 100% of votes cast. The meeting adopted the audited financial statements fo...
Beijing Health Expands Into China’s Sports and Digital Sports Market With Zhongtian Stake
May 29, 2026
Beijing Health (Holdings) Limited is accelerating its shift from a traditional &#8220;medical care + elderly care&#8221; model to a broader health ecosystem that includes proactive fitness and digital health management, aligning its business with ...
Beijing Health Sets 2026 AGM to Approve Accounts, Board Changes and Share Buyback Mandate
Apr 28, 2026
Beijing Health (Holdings) Limited has called its annual general meeting for 2 June 2026 in Hong Kong, where shareholders will review and adopt the 2025 audited financial statements and the reports of the board and auditors. The agenda also include...
Beijing Health Narrows Annual Loss Despite Higher Impairments in 2025
Mar 30, 2026
Beijing Health (Holdings) Limited reported a modest rise in revenue to HK$157.2 million for 2025 from HK$149.9 million a year earlier, with gross profit improving to HK$42.5 million. Despite the top-line growth and higher gross margin, the group r...
Beijing Health moves to modernise governance with electronic and capital-structure reforms
Mar 30, 2026
Beijing Health (Holdings) Limited plans to overhaul its memorandum and articles of association to align more closely with Hong Kong listing rules, Cayman Islands law and international best practices. The move positions the healthcare group to mode...
Beijing Health Updates Nomination Committee Mandate to Strengthen Board Governance
Mar 30, 2026
Beijing Health (Holdings) Limited has amended and restated the terms of reference of its Nomination Committee with effect from 30 March 2026, refining its composition, meeting procedures and governance arrangements. The committee must comprise at ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 17, 2026